Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Astemizole
Cat. No.:
OB0225LY-0130
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Astemizole is an antihistamine that is mainly used to relieve allergic reactions.
Synonym:
Laridal; Histaminos; Paralergin; 68844-77-9; 1-[(4-Fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]-1H-benzimidazol-2-amine; 1-(p-Fluorobenzyl)-2-((1-(p-methoxyphenethyl)-4-piperidyl)amino)benzimidazole; 1-[(4-Fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl]benzimidazol-2-amine; 1-[(4-Fluorophenyl)methyl]-N-{1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl}-1H-benzimidazol-2-amine
CAS No.:
68844-77-9
Compound CID:
2247
Formula:
C28H31FN4O
Formula Weight:
458.57
Specification
Relative Density:
1.2 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Astemizole can be used in research sessions seasonal allergic rhinitis and urticaria.
Library Information
Targets:
Histamine receptor; Potassium channel
Receptors:
H1 receptor
Pathways:
Neuronal signaling; GPCR/G protein; Immunology/Inflammation; Membrane transporter/Ion channel
Plate Number:
AOCL-2
Plate Location:
f3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 119.94 mM
